EUCOPE Blog

Showing all entries tagged with »medicines«

August 24, 2023

Trans-Atlantic Perspectives on the Future of Pharma

In this article, Michael N. Abrams and Alexander Natz discuss the current policy initiatives from Europe and the U.S., similarities between them, and implications for the pharmaceutical sector and their standing in a competitive global market. For years, lawmakers have… read more




December 19, 2022

Launch Conditionality: What’s at stake?

Based on current discussions by the European Commission, launch conditionalities would not account for the distinct nature of small and mid-sized companies, OMPs and ATMPs. EUCOPE’s Alexander Natz breaks down this aspect of the revision of the General Pharmaceutical Legislation… read more